سعر لورال 30مجم 10 كبسولة 2022

Loral 30 mg by Pharco (Egypt): lansoprazole capsules, a proton pump inhibitor that reduces gastric acid secretion.

• Short-term treatment (up to 8 weeks) of healing and symptom relief of benign gastric ulcer.Population: AdultsDailyMed (U.S. National Library of Medicine)
• Healing of NSAID-associated gastric ulcer in patients who continue NSAID use (8 weeks).Population: AdultsDailyMed (U.S. National Library of Medicine)
• Short-term treatment (up to 8 weeks) of erosive esophagitis (all grades).Population: AdultsDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions (1% or more): diarrhoea (3.8%), abdominal pain (2.1%), nausea (1.3%) and constipation (1.0%).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known severe hypersensitivity to any component; concomitant use with rilpivirine-containing products.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Symptomatic response does not exclude gastric malignancy; risks include acute tubulointerstitial nephritis, Clostridioides difficile-associated diarrhoea, bone fracture with high-dose/long-term use, severe cutaneous adverse reactions, cutaneous and systemic lupus erythematosus, vitamin B12 deficiency (over 3 years), hypomagnesaemia, interference with neuroendocrine tumour tests (chromogranin A) and fundic gland polyps; may raise methotrexate levels.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Rilpivirine; atazanavir, nelfinavir; saquinavirRilpivirine is contraindicated; avoid with atazanavir and nelfinavir (reduced antiviral effect); saquinavir levels may increase.DailyMed (U.S. National Library of Medicine)
• WarfarinIncreased INR and prothrombin time reported; monitor INR.DailyMed (U.S. National Library of Medicine)
• Methotrexate (high dose)May elevate and prolong methotrexate levels; temporary PPI withdrawal may be considered.DailyMed (U.S. National Library of Medicine)

• Available human observational data do not show an association with major malformations or adverse pregnancy outcomes; animal reproduction studies at high doses showed no adverse developmental effects for lansoprazole.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• No information on presence in human milk or effects on the breastfed infant; lansoprazole is present in rat milk. Weigh benefits against risks.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Lansoprazole: Suppresses gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system (proton pump) at the secretory surface of the gastric parietal cell.